These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21536114)

  • 21. Effervescent dry powder for respiratory drug delivery.
    Ely L; Roa W; Finlay WH; Löbenberg R
    Eur J Pharm Biopharm; 2007 Mar; 65(3):346-53. PubMed ID: 17156987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modification of electrostatic charge on inhaled carrier lactose particles by addition of fine particles.
    Bennett FS; Carter PA; Rowley G; Dandiker Y
    Drug Dev Ind Pharm; 1999 Jan; 25(1):99-103. PubMed ID: 10028425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dissolution rate enhancement of gliclazide by ordered mixing.
    Saharan VA; Choudhury PK
    Acta Pharm; 2011 Sep; 61(3):323-34. PubMed ID: 21945911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A toolbox for the upscaling of ethanolic human serum albumin (HSA) desolvation.
    Wacker M; Zensi A; Kufleitner J; Ruff A; Schütz J; Stockburger T; Marstaller T; Vogel V
    Int J Pharm; 2011 Jul; 414(1-2):225-32. PubMed ID: 21571055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Understanding the influence of powder flowability, fluidization and de-agglomeration characteristics on the aerosolization of pharmaceutical model powders.
    Zhou QT; Armstrong B; Larson I; Stewart PJ; Morton DA
    Eur J Pharm Sci; 2010 Aug; 40(5):412-21. PubMed ID: 20433919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhalation performance of pollen-shape carrier in dry powder formulation: effect of size and surface morphology.
    Hassan MS; Lau R
    Int J Pharm; 2011 Jul; 413(1-2):93-102. PubMed ID: 21540087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of high shear blending on alpha-lactose monohydrate.
    Bridson RH; Robbins PT; Chen Y; Westerman D; Gillham CR; Roche TC; Seville JP
    Int J Pharm; 2007 Jul; 339(1-2):84-90. PubMed ID: 17398047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Engineered mannitol as an alternative carrier to enhance deep lung penetration of salbutamol sulphate from dry powder inhaler.
    Kaialy W; Momin MN; Ticehurst MD; Murphy J; Nokhodchi A
    Colloids Surf B Biointerfaces; 2010 Sep; 79(2):345-56. PubMed ID: 20537870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation of chitosan microspheres by ionotropic gelation under a high voltage electrostatic field for protein delivery.
    Ma L; Liu C
    Colloids Surf B Biointerfaces; 2010 Feb; 75(2):448-53. PubMed ID: 19819676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incorporation of acetaminophen as an active pharmaceutical ingredient into porous lactose.
    Ebrahimi A; Saffari M; Dehghani F; Langrish T
    Int J Pharm; 2016 Feb; 499(1-2):217-227. PubMed ID: 26768724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The enhanced aerosol performance of salbutamol from dry powders containing engineered mannitol as excipient.
    Kaialy W; Martin GP; Ticehurst MD; Momin MN; Nokhodchi A
    Int J Pharm; 2010 Jun; 392(1-2):178-88. PubMed ID: 20363301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors affecting the particle size and in vitro release of bovine serum albumin from polyethylene glycol microparticles.
    Thummala AS; Leach JK; O'Rear EA
    Biomed Sci Instrum; 2003; 39():318-23. PubMed ID: 12724913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of triboelectric charging in dry powder inhalers using electrical low pressure impactor (ELPI).
    Telko MJ; Kujanpää J; Hickey AJ
    Int J Pharm; 2007 May; 336(2):352-60. PubMed ID: 17218072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electrohydrodynamic atomization for biodegradable polymeric particle production.
    Xie J; Lim LK; Phua Y; Hua J; Wang CH
    J Colloid Interface Sci; 2006 Oct; 302(1):103-12. PubMed ID: 16842810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spray-freeze-drying production of thermally sensitive polymeric nanoparticle aggregates for inhaled drug delivery: effect of freeze-drying adjuvants.
    Cheow WS; Ng ML; Kho K; Hadinoto K
    Int J Pharm; 2011 Feb; 404(1-2):289-300. PubMed ID: 21093560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Encapsulation of proteins in biodegradable polymeric microparticles using electrospray in the Taylor cone-jet mode.
    Xie J; Wang CH
    Biotechnol Bioeng; 2007 Aug; 97(5):1278-90. PubMed ID: 17216662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aerosolization properties, surface composition and physical state of spray-dried protein powders.
    Bosquillon C; Rouxhet PG; Ahimou F; Simon D; Culot C; Préat V; Vanbever R
    J Control Release; 2004 Oct; 99(3):357-67. PubMed ID: 15451594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simultaneous production and co-mixing of microparticles of nevirapine with excipients by supercritical antisolvent method for dissolution enhancement.
    Sanganwar GP; Sathigari S; Babu RJ; Gupta RB
    Eur J Pharm Sci; 2010 Jan; 39(1-3):164-74. PubMed ID: 19961931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measurement of electrostatic charge decay in pharmaceutical powders and polymer materials used in dry powder inhaler devices.
    Carter PA; Rowley G; Fletcher EJ; Stylianopoulos V
    Drug Dev Ind Pharm; 1998 Nov; 24(11):1083-8. PubMed ID: 9876564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynamic electrostatic charge of lactose-salbutamol sulphate powder blends dispersed from a Cyclohaler®.
    Hoe S; Young PM; Traini D
    Drug Dev Ind Pharm; 2011 Nov; 37(11):1365-75. PubMed ID: 21554161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.